Drugs / pUMVC3-hIGFBP-2
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01322802 | Mar 2012 → Jan 2015 | ovarian carcinoma, ovarian germ cell tumor | University of Washington | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | pUMVC3-hIGFBP-2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01322802 ↗ |
| Modality | Vaccine | “DNA plasmid based vaccine” NCT01322802 ↗ |